StevenCGoldsteinMD

Physician

Dr. Goldstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

22 citations
Impact of Next-Generation Sequencing Cell-free Pathogen DNA Test on Antimicrobial Management in Adults with Hematological Malignancies and Transplant Recipients with S...
James B. Yu, Juan D. Diaz, Steven C. Goldstein, Rushang D. Patel, Juan C. Varela
Transplantation and Cellular Therapy. 2021-02-26
20 citations
Conditioning regimen intensity and low-dose azacitidine maintenance after allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
Naveed Ali, Benjamin Tomlinson, Leland Metheny, Steven C. Goldstein, Pingfu Fu
Leukemia & Lymphoma. 2020-07-10
39 citations
Eltrombopag for Treating Thrombocytopenia after Allogeneic Stem Cell Transplantation
Cai Yuan, Angela M. Boyd, Jan Nelson, Rushang D. Patel, Juan C. Varela
Biology of Blood and Marrow Transplantation. 2019-07-01

Journal Articles

Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma (L-NN-MCL) with P53 Gene Re-arrangement/Mutation Is Highly Responsive to Rituximab/Ibrutinib Combination Therapy
Shahram Mori, Juan Varela, Steven C Goldstein, Daniel O Persky, Clinical Lymphoma, Myeloma, & Leukemia

Aggressive Leukemic Non-Nodal Mantle Cell Lymphoma (L-NN-MCL) with P53 Gene Re-arrangement/Mutation Is Highly Responsive to Rituximab/Ibrutinib Combination TherapyNovember 2018